Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Krystal Biotech, Inc.
Business Segments
Business Segments
Gain from sale of priority review voucher
Gain from sale of priority review voucher
Krystal Biotech, Inc.
·
Business Segments
·
1 segment
·
Rolls up to
Gain (loss) on disposal of assets
Breakdown
Segments
Business Segments
View metric
Annual
Segment
FY'25
Business Segments
$0
Total
$0
All segment values are derived from annual filings.